In-use stability modeling.

Area of Science:

• Pharmaceutical Sciences
• Analytical Chemistry
• Chemical Engineering

Background:

• In-use stability testing is crucial for pharmaceutical products to ensure efficacy and safety after opening.
• Existing methods often lack flexibility in estimating degradation over various usage scenarios.
• Understanding degradation kinetics in open containers is essential for defining product shelf-life.

Purpose of the Study:

• To develop and present experimental designs and modeling approaches for in-use stability testing.
• To estimate degradation of products in open containers considering time and usage instances.
• To introduce two distinct models: a fixed model and a general model for degradation estimation.

Main Methods:

• Investigated in-use open container degradation based on time and/or number of container uses.
• Developed a fixed model to estimate degradation at specific closed container time points with available data.
• Developed a general model to estimate degradation at any closed container time point using established relationships.

Main Results:

• The general model enables in-use degradation estimation at any time point within the experimental range, even if data wasn't collected at that exact time.
• Degradation estimation is feasible as long as the time point falls within the experiment's defined range.
• Product stability is quantified as the cumulative drift from initial time, accounting for both closed and in-use open container phases.

Conclusions:

• The proposed modeling approaches provide a robust framework for assessing in-use stability of pharmaceutical products.
• The general model offers enhanced flexibility for predicting degradation, reducing the need for extensive data collection at all desired time points.
• Accurate estimation of in-use degradation is vital for extending product shelf-life and ensuring patient safety.